INDP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Indaptus Therapeutics Inc (INDP) is not a strong buy for a beginner investor with a long-term strategy at this time. The lack of positive financial performance, neutral trading sentiment, and absence of significant catalysts make it unsuitable for immediate investment.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 49.393, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest limited upward movement in the short term.
The stock has an 80% chance of gaining 4.05% in the next day, 10.64% in the next week, and 11.97% in the next month based on similar candlestick patterns.
No recent news or significant trading trends from hedge funds or insiders. The financial performance is weak, with declining net income and EPS. No recent congress trading data is available.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped by -3.06% YoY to -$2,975,117, and EPS fell significantly by -67.04% YoY to -2.98. Gross margin remains at 0.
No recent analyst ratings or price target changes are available.
